Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Caputo

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
NPJ Breast Cancer|January 18, 2022
Value of the loss of heterozygosity to BRCA1 variant classificationElizabeth Santana Dos Santos, Amanda B Spurdle, Dirce M Carraro, et al.
Cellular and Molecular Neurobiology|June 5, 2026
Postmortem Evidence of Lymphatic Vessels Located at the Boundary of Central and Peripheral Nervous Systems in the Cervical SpineShalin S Bhatt, Caitlin R Coker, Lauren K Bagian, et al.
Cancers|July 2, 2021
5' Region Large Genomic Rearrangements in the <i>BRCA1</i> Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent BreakpointsSandrine M Caputo, Dominique Telly, Adrien Briaux, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Cancer Discovery|April 24, 2021
NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer InitiationAlexandros Papachristodoulou, Antonio Rodriguez-Calero, Sukanya Panja, et al.
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
Cancer Research|February 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo, et al.
Nucleic Acids Research|October 16, 2018
Corrigendum: Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald L Gac, et al.
Oncotarget|May 1, 2018
Full in-frame exon 3 skipping of <i>BRCA2</i> confers high risk of breast and/or ovarian cancerSandrine M Caputo, Mélanie Léone, Francesca Damiola, et al.
Nucleic Acids Research|December 22, 2019
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald Le Gac, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
NPJ Breast Cancer|January 18, 2022
Value of the loss of heterozygosity to BRCA1 variant classificationElizabeth Santana Dos Santos, Amanda B Spurdle, Dirce M Carraro, et al.
Cellular and Molecular Neurobiology|June 5, 2026
Postmortem Evidence of Lymphatic Vessels Located at the Boundary of Central and Peripheral Nervous Systems in the Cervical SpineShalin S Bhatt, Caitlin R Coker, Lauren K Bagian, et al.
Cancers|July 2, 2021
5' Region Large Genomic Rearrangements in the <i>BRCA1</i> Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent BreakpointsSandrine M Caputo, Dominique Telly, Adrien Briaux, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Cancer Discovery|April 24, 2021
NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer InitiationAlexandros Papachristodoulou, Antonio Rodriguez-Calero, Sukanya Panja, et al.
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
Cancer Research|February 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo, et al.
Nucleic Acids Research|October 16, 2018
Corrigendum: Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald L Gac, et al.
Oncotarget|May 1, 2018
Full in-frame exon 3 skipping of <i>BRCA2</i> confers high risk of breast and/or ovarian cancerSandrine M Caputo, Mélanie Léone, Francesca Damiola, et al.
Nucleic Acids Research|December 22, 2019
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald Le Gac, et al.
Pageof 37